Echinacea
13 benefits mapped to clinical evidence across supplements.
Dose per serving from products
470 products in our catalogue print how much Echinacea a serving holds.
Most common: 250 mg to 500 mg, 27% of 470 products.
| Dose per serving | Products |
|---|---|
| 10 mg or less | 22 |
| 10 mg to 25 mg | 50 |
| 25 mg to 50 mg | 71 |
| 50 mg to 100 mg | 80 |
| 100 mg to 250 mg | 63 |
| 250 mg to 500 mg | 127 |
| 500 mg to 1 g | 49 |
| over 1 g | 8 |
Dose per serving from research
10 study groups in 8 studies say how much Echinacea participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 g to 2.5 g, 30% of 10 study groups.
| Daily dose | Study groups |
|---|---|
| 50 mg or less | 1 |
| 50 mg to 100 mg | 1 |
| 100 mg to 250 mg | 2 |
| 250 mg to 500 mg | 2 |
| 500 mg to 1 g | 1 |
| 1 g to 2.5 g | 3 |
Benefit Evidence
Research sources
Cold/flu relief (10)
- Echinacea purpurea and mucosal immunity
PubMed ID: 17436202
Exercise study reported much shorter URTI duration (~3.4 vs 8.6 days) with echinacea—strong duration reduction in that small trial.
- Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
PubMed ID: 39769201
Blend including Echinacea lowered number of patients with multiple concurrent symptoms and decreased sore throat incidents and fever days.
- Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial
PubMed ID: 33832544
Four-month preventive Echinacea substantially reduced cumulative cold days and episode duration in children (large RCT).
- Echinacea can help with Azithromycin in prevention of recurrent tonsillitis in children
PubMed ID: 32487336
Adjunct Echinacea reduced frequency and severity of recurrent tonsillitis attacks, consistent with shorter/milder upper RTI episodes (confounded).
- Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial
PubMed ID: 10228604
Echinaforce and concentrated E. purpurea produced significant reductions in common‑cold symptom complaint index vs placebo — strong symptomatic benefit for specific preparations.
- Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study
PubMed ID: 10621929
Herbal combination including Echinacea yielded earlier and measurable symptom improvement and better general well‑being vs placebo (multi‑herb evidence).
- The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study
PubMed ID: 10976979
Compound Echinacea tea reduced severity of cold/flu symptoms versus placebo (self‑reported).
- Efficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trial
PubMed ID: 11505787
Randomized double‑blind trial showed a clinically meaningful reduction in median cold duration (~3 days) with Echinacea.
- Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study
PubMed ID: 14993078
Children given an echinacea+propolis+vitC product had substantially fewer and shorter respiratory illnesses—large effect for the combination, but attribution to echinacea alone is uncertain.
- Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial
PubMed ID: 14748902
Standardized echinacea started at cold onset reduced symptom severity by ~23% in per‑protocol analysis—good support for milder symptoms in adherent adults.
Illness recovery (9)
- Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial
PubMed ID: 10228604
Specific E. purpurea extracts reduced cold symptom scores faster than placebo — supports faster recovery.
- Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
PubMed ID: 39769201
Reduced symptom burden and enhanced ex vivo antiviral activity suggest quicker resolution, though study used a multi-ingredient blend.
- Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial
PubMed ID: 33832544
Fewer cumulative cold days and shorter mean episode duration indicate faster recovery in children using preventive Echinacea.
- Echinacea can help with Azithromycin in prevention of recurrent tonsillitis in children
PubMed ID: 32487336
Adjunct use reduced attack frequency and symptom severity in recurrent tonsillitis, implying faster/less severe episodes (confounded).
- Echinacea purpurea and mucosal immunity
PubMed ID: 17436202
Exercise study participants taking echinacea had markedly shorter URTI duration—faster recovery in that specific population.
- Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study
PubMed ID: 14993078
Children taking echinacea+propolis+vitC had fewer/shorter illnesses and less fever—combination showed faster recovery/less morbidity.
- Efficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trial
PubMed ID: 11505787
Demonstrated a 3‑day reduction in median cold duration — direct evidence of faster recovery from a minor illness (common cold).
- The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study
PubMed ID: 10976979
Compound herbal tea including Echinacea shortened symptom duration and severity — multi‑herb evidence for quicker recovery.
- Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study
PubMed ID: 10621929
Herbal combination including Echinacea produced earlier symptom improvement and better well‑being in acute respiratory illness.
Immune support (9)
- A randomized, double-blind, placebo-controlled study on immune improvement effects of ethanolic extract of Echinacea purpurea (L.) Moench in Korean adults
PubMed ID: 38743584
8‑week RCT in healthy adults showed increased NK cell activity and rises in IL‑2/IFN‑γ/TNF‑α — clear immunomodulatory effect.
- Immunological activity of larch arabinogalactan and Echinacea: a preliminary, randomized, double-blind, placebo-controlled trial
PubMed ID: 11991793
4‑week RCT increased complement properdin (~21%) and improved SF‑36 domains, indicating modest immune stimulation.
- Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea
PubMed ID: 9395611
Small trials reported increases in neutrophil phagocytosis (inconsistent across preparations) — supportive innate immune effects.
- Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study
PubMed ID: 14993078
12‑week study in children showed substantially fewer and shorter respiratory illnesses with echinacea+propolis+vitC—suggests seasonal prophylactic benefit for that combination.
- Echinacea purpurea and mucosal immunity
PubMed ID: 17436202
Preserved salivary IgA after exercise and substantially shorter URTI duration—supports mucosal immune benefit in stressed subjects.
- Echinacea can help with Azithromycin in prevention of recurrent tonsillitis in children
PubMed ID: 32487336
Adjunct Echinacea reduced tonsillitis attack frequency/severity when added to azithromycin (supports immune benefit though confounded).
- Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial
PubMed ID: 33832544
Preventive daily Echinacea in children reduced RTI incidence by ~32.5% and antibiotic use—strong seasonal prophylactic evidence.
- Echinacea angustifolia and Echinacea purpurea Supplementation Combined with Vaginal Hyaluronic Acid to Boost the Remission of Cervical Low-Grade Squamous Intraepithelial Lesions (L-SILs): A Randomized Controlled Trial
PubMed ID: 35630063
Oral Echinacea combined with vaginal therapy raised regression of low-grade cervical lesions, suggesting immune/antiviral activity (combined therapy).
- Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
PubMed ID: 39769201
Randomized trial of a polyphenol blend including Echinacea increased ex vivo antiviral activity and cytokine responses.
Cough & throat (7)
- Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial
PubMed ID: 19748859
Echinacea+sage throat spray reduced throat pain and CRP comparably to active lidocaine/chlorhexidine—strong oral/throat symptomatic and inflammatory benefit for the formulation.
- Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study
PubMed ID: 10621929
Herbal combination including Echinacea improved global symptom scores for rhinitis/bronchitis — likely included cough improvement (multi‑ingredient evidence).
- Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial
PubMed ID: 10228604
Trial showed overall reduction in cold symptom scores including upper respiratory complaints; may include sore throat relief for some preparations.
- Antitussive effect of a fixed combination of Justicia adhatoda, Echinacea purpurea and Eleutherococcus senticosus extracts in patients with acute upper respiratory tract infection: A comparative, randomized, double-blind, placebo-controlled study
PubMed ID: 26598919
Randomized trial found Kan Jang relieved cough faster than placebo—supports cough relief for the product.
- Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
PubMed ID: 39769201
Blend including Echinacea reduced overall respiratory symptom burden including cough-related measures in susceptible adults.
- Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial
PubMed ID: 33832544
Preventive Echinacea reduced RTI days and symptom burden in children, likely including cough episodes.
- Echinacea can help with Azithromycin in prevention of recurrent tonsillitis in children
PubMed ID: 32487336
Adjunctive Echinacea reduced tonsillitis attack frequency and symptom severity (directly relevant to throat comfort).
Respiratory comfort (7)
- Echinacea can help with Azithromycin in prevention of recurrent tonsillitis in children
PubMed ID: 32487336
Adjunct Echinacea reduced tonsillitis attack frequency and symptom severity, relevant to upper respiratory comfort.
- Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial
PubMed ID: 33832544
Preventive Echinacea in children reduced respiratory infection days and complications, indicating improved respiratory comfort overall.
- Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
PubMed ID: 39769201
Polyphenol blend including Echinacea reduced respiratory symptom burden and fever days in susceptible adults.
- Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial
PubMed ID: 10228604
Randomized trial (E. purpurea preparations) reduced common‑cold symptom scores faster than placebo — direct respiratory symptom benefit.
- Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study
PubMed ID: 10621929
Multicentre trial of a fixed herbal combination (including Echinacea) produced earlier symptom improvement in acute colds/bronchitis — supports respiratory comfort (multi‑ingredient).
- Efficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trial
PubMed ID: 11505787
Trial shortened median cold duration by ~3 days, implying better overall respiratory recovery.
- Antitussive effect of a fixed combination of Justicia adhatoda, Echinacea purpurea and Eleutherococcus senticosus extracts in patients with acute upper respiratory tract infection: A comparative, randomized, double-blind, placebo-controlled study
PubMed ID: 26598919
Randomized trial: Kan Jang (contains E. purpurea) relieved cough faster than placebo—antitussive/respiratory comfort signal for the product.
Stress resilience (6)
- Echinacea purpurea and mucosal immunity
PubMed ID: 17436202
Preservation of mucosal IgA and much shorter URTI duration in an exercise‑stressed group indicate improved resilience under physiologic stress.
- Immunological activity of larch arabinogalactan and Echinacea: a preliminary, randomized, double-blind, placebo-controlled trial
PubMed ID: 11991793
Increase in complement properdin and better SF‑36 scores imply modest enhancement of physiological resilience and wellbeing.
- Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study
PubMed ID: 14993078
12‑week pediatric study of a combination product showed fewer/shorter illnesses and less fever—suggests improved resilience to seasonal infections for the combination.
- A randomized, double-blind, placebo-controlled study on immune improvement effects of ethanolic extract of Echinacea purpurea (L.) Moench in Korean adults
PubMed ID: 38743584
Significant increases in NK cell activity and key cytokines in healthy adults suggest enhanced immunologic responsiveness/resilience.
- Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial
PubMed ID: 33832544
Preventive reduction in RTI incidence, complications and antibiotic use in children reflects enhanced resilience to common infections.
- Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
PubMed ID: 39769201
Enhanced ex vivo antiviral activity and reduced symptom burden with a polyphenol/Echinacea blend support a resilience signal.
Wellbeing (4)
- An investigation into the anxiety-relieving and mood-enhancing effects of Echinacea angustifolia (EP107™): A randomised, double-blind, placebo-controlled study
PubMed ID: 34217960
Echinacea angustifolia improved positive affect and emotional wellbeing on secondary outcomes, aligning with subjective wellness benefits.
- Immunological activity of larch arabinogalactan and Echinacea: a preliminary, randomized, double-blind, placebo-controlled trial
PubMed ID: 11991793
SF‑36 domains (physical, vitality, emotional) improved after 4 weeks in healthy women — supports a general wellness/quality‑of‑life benefit.
- Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study
PubMed ID: 10621929
Herbal combination including Echinacea improved general well‑being during acute illness — multi‑ingredient evidence for perceived wellness benefits.
- Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial
PubMed ID: 33832544
Fewer RTI days/complications and less antibiotic use in children could translate to improved overall wellness.
Inflammation (4)
- Effect of an herbal mouth rinse in preventing periodontal inflammation in an experimental gingivitis model: a pilot study
PubMed ID: 22479786
Herbal mouth rinse (contains echinacea) reduced gingival inflammation versus controls in a pilot trial—localized anti‑inflammatory benefit for the product.
- A phase II trial of a transmucosal herbal patch for the treatment of gingivitis
PubMed ID: 21965490
Herbal periodontal patch containing echinacea reduced gingival inflammation and inflammatory enzyme levels in a small RCT—localized anti‑inflammatory effect for the formulation.
- Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial
PubMed ID: 19748859
Echinacea+sage throat spray produced large symptom reductions and CRP decrease similar to active comparator—strong clinical anti‑inflammatory signal for the formulation.
- Effects of Plant Meristem-Cell-Based Cosmetics on Menopausal Skin: Clinical Data and Mechanisms
PubMed ID: 39334942
Topical serums containing Echinacea reduced skin lipid peroxidation (MDA) and improved dermal markers implying reduced local oxidative/inflammatory stress (cosmetic trial).
Mucus clearance (3)
- Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study
PubMed ID: 10621929
Multicentre herbal combination including Echinacea improved rhinitis/bronchitis symptom scores — likely includes sinus symptom relief (multi‑herb evidence).
- Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial
PubMed ID: 33832544
Large reduction in RTI days and complications implies improved sinonasal comfort though sinus outcomes not isolated.
- Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial
PubMed ID: 10228604
Specific E. purpurea extracts reduced cold complaint index vs placebo — benefits likely extend to sinus complaints.
Antioxidant (1)
- Effects of Plant Meristem-Cell-Based Cosmetics on Menopausal Skin: Clinical Data and Mechanisms
PubMed ID: 39334942
Topical serums containing Echinacea lowered skin lipid peroxidation (MDA) and improved dermal collagen markers — direct antioxidant marker improvement in humans (cosmetic trial, multi‑extract).
Skin repair (1)
- Effects of Plant Meristem-Cell-Based Cosmetics on Menopausal Skin: Clinical Data and Mechanisms
PubMed ID: 39334942
Topical meristem extract serums (including Echinacea) improved skin elasticity, increased dermal collagen markers (hydroxyproline/dermal thickness) and decreased lipid peroxidation in menopausal women — direct skin repair markers.
Skin soothing (1)
- Effects of Plant Meristem-Cell-Based Cosmetics on Menopausal Skin: Clinical Data and Mechanisms
PubMed ID: 39334942
Topical serums with Echinacea improved skin biophysical markers and reduced lipid oxidation — supports soothing/skin health effects in menopausal women (multi‑extract).
Vitality (1)
- Immunological activity of larch arabinogalactan and Echinacea: a preliminary, randomized, double-blind, placebo-controlled trial
PubMed ID: 11991793
SF‑36 vitality domain improved with 4 weeks of Echinacea preparation — direct measure of increased vitality.
Forms of Echinacea
The 4 forms a label may print instead of Echinacea. Each is a different substance with its own identifier, and none of them has research of its own — the studies are the ones on this page.
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Echinacea
Search all1421 products whose verified label declares Echinacea — not every bottle that mentions it in a title.